Pliant Therapeutics Inc (PLRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.16+2.65%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PLRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | 1.6 | 9.7 | 7.6 | 41.8 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 63.8 | 109.2 | 169.3 | 127.8 | 96.9 | 77.5 | 66.2 |
| Operating Income | (97.5) | (156.4) | (228.4) | (184.1) | (127.2) | (97.5) | (41.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 2.6 | 3.0 | 1.3 | 0.8 | 0.0 | — |
| Interest & Investment Income | — | — | — | — | — | — | 0.5 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | 206.4 | (149.3) | (210.3) | 161.3 | (123.3) | (97.3) | (41.5) |
| Per Share | |||||||
| Basic EPS | 3.33 | (2.43) | (3.47) | (2.75) | (2.94) | (2.71) | (1.95) |
| Diluted EPS | 3.33 | (2.43) | (3.47) | (2.75) | (2.94) | (2.71) | (1.95) |
| Dividend per Share | — | — | — | 0.00 | 0.00 | — | — |
| Basic Weighted Avg Shares | 61.9 | 61.4 | 60.5 | 58.7 | 42.0 | 35.8 | 21.3 |
| Diluted Weighted Avg Shares | 61.9 | 61.4 | 60.5 | 58.7 | 42.0 | 35.8 | 21.3 |
| Supplemental | |||||||
| EBIT | (97.5) | (156.4) | (228.4) | (184.1) | (127.2) | (97.5) | (41.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.